The Medtronic RESOLUTE US Clinical Trial
Completed · Not applicable
Conditions studied: Coronary Artery Disease
In brief
The objective of the study is to assess the safety and effectiveness of the Resolute Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter (RVD) of 2.25 mm to 4.2 mm.
Key facts
- Study ID
- NCT00726453
- Run by
- Medtronic Vascular
- People needed
- 1516
- Starts
- 2008-07-01
- Expected to finish
- 2016-03-01
- Last updated by the study team
- 2016-05-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- East Texas Medical Center — Tyler, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.